家禽疫苗市场－全球产业规模、份额、趋势、机会及预测（按应用、产品、疾病类型、地区和竞争细分，2020-2030 年）

2024 年全球家禽疫苗市场价值为 18.9 亿美元，预计到 2030 年将达到 27.8 亿美元，预测期内复合年增长率为 6.64%。由于家禽养殖仍然是全球粮食供应的基石，家禽疫苗市场在维持家禽健康和确保粮食安全方面发挥着至关重要的作用。传染性法氏囊病 (IBD) 等禽类疾病的盛行率不断上升，加上家禽产品的日益普及，推动了对有效免疫策略的需求。最近的人畜共患病疫情和家禽病毒感染发病率的上升，特别是在非洲和亚洲等地区，进一步强调了广泛疫苗接种计划的必要性。疫苗开发技术的进步，包括重组疫苗和基于 DNA 的疫苗，正在促进市场的演变。此外，政府和兽医组织越来越重视疾病管制，以防止家禽业的经济损失，这强调了疫苗在维持家禽养殖生产力和健康标准的重要性。

关键市场驱动因素

全球家禽消费量上升

主要市场挑战

疾病的复杂性和多变性

主要市场趋势

精准疫苗接种

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球家禽疫苗市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依用途（肉鸡、蛋鸡、种鸡）
  • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
  • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、产蛋减少症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌病、其他）
  • 按地区
  • 按公司分类（2024）
• 产品市场图
  • 按应用
  • 按产品
  • 依疾病类型
  • 按地区

第六章：北美家禽疫苗市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲家禽疫苗市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太家禽疫苗市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第九章：南美洲家禽疫苗市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲家禽疫苗市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Boehringer Ingelheim GmbH
• Zoetis Inc
• Elanco LLC
• Intervet Inc
• Hester Biosciences Ltd
• Vaxxinova GmbH
• Venky's India Ltd
• Laboratorios Calier SA
• KM Biologics Co Ltd
• Phibro Animal Health Corporation

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Poultry Vaccines Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.78 billion by 2030, growing at a CAGR of 6.64% during the forecast period. As poultry farming remains a cornerstone of the global food supply, the market for poultry vaccines plays a vital role in maintaining flock health and ensuring food security. The increasing prevalence of avian diseases, such as Infectious Bursal Disease (IBD), coupled with the growing popularity of poultry products, is driving the demand for effective immunization strategies. Recent zoonotic outbreaks and the rising incidence of viral infections in poultry, particularly in regions like Africa and Asia, are further emphasizing the need for widespread vaccination programs. Technological advancements in vaccine development, including recombinant and DNA-based vaccines, are contributing to the market's evolution. Moreover, governments and veterinary organizations are increasingly focused on disease control to prevent economic losses in the poultry industry, reinforcing the importance of vaccines in sustaining productivity and health standards in poultry farming.

Key Market Drivers

Rising Global Poultry Consumption

The steady increase in global poultry consumption is significantly contributing to the expansion of the poultry vaccines market. Poultry, particularly chicken, has become a preferred protein source due to its affordability, nutritional value, and adaptability in diverse cuisines. As populations grow and urbanization accelerates, the demand for poultry meat and eggs continues to rise. This surge in consumption amplifies the need for disease prevention to protect flock health and ensure stable supply chains. Poultry farming is highly susceptible to disease outbreaks, which can result in massive financial losses and disruptions in production. Diseases like Newcastle disease, avian influenza, and coccidiosis are particularly prevalent and costly. For instance, a study reported in IJCMAS in October 2021 detailed financial losses ranging from INR 17,864 (USD 214) to INR 2,66,080 (USD 3,188.89) per farm due to Newcastle disease, further highlighting the critical need for robust vaccination programs. As a result, maintaining flock health through vaccination is becoming a key strategy for producers to safeguard economic returns and meet growing consumer demand.

Key Market Challenges

Disease Complexity and Variability

The poultry vaccines market faces notable challenges stemming from the complexity and variability of infectious diseases affecting poultry. Poultry are vulnerable to a broad spectrum of pathogens, including viruses, bacteria, and parasites, each with multiple strains and high mutation rates. This diversity complicates the development of vaccines that can offer comprehensive and long-lasting protection. Continual pathogen evolution necessitates constant updates in vaccine formulations, increasing research and development costs. Moreover, the unpredictable emergence of novel variants can outpace the availability of suitable vaccines, undermining disease control efforts and adding uncertainty to vaccine efficacy.

Key Market Trends

Precision Vaccination

Precision vaccination is emerging as a key trend in the poultry vaccines market, with the focus shifting toward more targeted and efficient immunization strategies. This approach tailors vaccination programs based on specific factors such as the age, health status, and risk profile of poultry flocks. Through the use of data analytics and advanced monitoring systems, precision vaccination enables better disease forecasting and more accurate administration schedules. The result is enhanced vaccine effectiveness, reduced wastage, and cost optimization. This trend aligns with the broader movement toward data-driven, sustainable practices in animal agriculture and reflects the industry's commitment to maximizing productivity while minimizing intervention-related costs.

Key Market Players

• Boehringer Ingelheim GmbH
• Zoetis Inc
• Elanco LLC
• Intervet Inc
• Hester Biosciences Ltd
• Vaxxinova GmbH
• Venky's India Ltd
• Laboratorios Calier SA
• KM Biologics Co Ltd
• Phibro Animal Health Corporation

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application:

• Broiler
• Layer
• Breeder

Poultry Vaccines Market, By Product:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Poultry Vaccines Market, By Disease Type:

• Infectious Bronchitis
• Infectious Bursal Diseases
• Infectious Laryngotracheitis
• Egg Drop Syndrome
• Adenovirus
• Duck Viral Enteritis
• Inclusion Body Hepatitis
• Salmonella
• Others

Poultry Vaccines Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Broiler, Layer, Breeder)
  • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Application
  • 5.3.2. By Product
  • 5.3.3. By Disease Type
  • 5.3.4. By Region

6. North America Poultry Vaccines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application (Broiler, Layer, Breeder)
  • 6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Vaccines Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease Type
  • 6.3.2. Canada Poultry Vaccines Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease Type
  • 6.3.3. Mexico Poultry Vaccines Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application (Broiler, Layer, Breeder)
  • 7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Poultry Vaccines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease Type
  • 7.3.2. United Kingdom Poultry Vaccines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease Type
  • 7.3.3. France Poultry Vaccines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease Type
  • 7.3.4. Italy Poultry Vaccines Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease Type
  • 7.3.5. Spain Poultry Vaccines Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Poultry Vaccines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application (Broiler, Layer, Breeder)
  • 8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Poultry Vaccines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease Type
  • 8.3.2. Japan Poultry Vaccines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease Type
  • 8.3.3. India Poultry Vaccines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease Type
  • 8.3.4. Australia Poultry Vaccines Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease Type
  • 8.3.5. South Korea Poultry Vaccines Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease Type

9. South America Poultry Vaccines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application (Broiler, Layer, Breeder)
  • 9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Poultry Vaccines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease Type
  • 9.3.2. Argentina Poultry Vaccines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease Type
  • 9.3.3. Colombia Poultry Vaccines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Poultry Vaccines Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application (Broiler, Layer, Breeder)
  • 10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Poultry Vaccines Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease Type
  • 10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease Type
  • 10.3.3. UAE Poultry Vaccines Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Boehringer Ingelheim GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Zoetis Inc
• 14.3. Elanco LLC
• 14.4. Intervet Inc
• 14.5. Hester Biosciences Ltd
• 14.6. Vaxxinova GmbH
• 14.7. Venky's India Ltd
• 14.8. Laboratorios Calier SA
• 14.9. KM Biologics Co Ltd
• 14.10. Phibro Animal Health Corporation

15. Strategic Recommendations

16. About Us & Disclaimer